Series B startup

Who invested in Splisense

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$29Mraised across 1 round since 2021, from 1 source

Latest round
Series B, $29MMay 2021
Investors
1
See who backed them

The rounds

  1. May 2021
    Series B$29M

    Source recorded

Founders and team

From Splisense's own website: 3 on the team.

  • Dr. Gili HartCEO
  • Lital FriedmanTeam
  • Regulatory AffairsTeam

Everyone who backed them

OrbiMedPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Splisense

Who invested in Splisense?

Splisense's investors include OrbiMed.

How much has Splisense raised?

Splisense has raised $29M across 1 round since 2021.

When did Splisense last raise?

Splisense's most recent round was a Series B of $29M in May 2021.

What was Splisense's biggest round?

Its most recent round, $29M in May 2021, is also its largest on record.

Who backed Splisense first?

Splisense's first round on record, in May 2021, was backed by OrbiMed.

What stage is Splisense at?

Splisense's latest named round is a Series B, in May 2021.

Companies like Splisense

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.